English

SCPHARMACEUTICALS INC.

EDGAR

SCPH Quarterly report (10-Q) · filed 2025-08-07

37 filing records in this dataset, filed from 2017-10-23 to 2025-08-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 40.8 million USD 2025-06-30 Source
Exact value

40800000 USD
Long-term debt including current maturities: 40 million USD 2024-06-30 Source
Exact value

39990000 USD
Shares outstanding: 53.3 million shares 2025-06-30 Source
Exact value

53290227 shares

Reported share-count change

47.46% · 17.2 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

36139802 shares · 2024-06-30· Source
53290227 shares · 2025-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-91.7 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence

Net income: -35105000 USD · 2024-07-01 – 2024-09-30 Source
Net income: -85148000 USD · 2024-01-01 – 2024-12-31 Source
Net income: -66303000 USD · 2024-01-01 – 2024-09-30 Source
Net income: -19742000 USD · 2025-01-01 – 2025-03-31 Source
Net income: -18024000 USD · 2025-04-01 – 2025-06-30 Source

Operating cash flow

-65.8 million USD

2024-07-01 – 2025-06-30

Exact inputs and evidence

Operating cash flow: -55352000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -37928000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -70500000 USD · 2024-01-01 – 2024-12-31 Source
Operating cash flow: -55352000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -17139000 USD · 2025-01-01 – 2025-03-31 Source
Operating cash flow: -33250000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -17139000 USD · 2025-01-01 – 2025-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-08-07.

Financial data available through: 2024-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 9 of 11 periods available· newest 2024-12-31
Net income: 9 of 11 periods available· newest 2024-12-31
Operating cash flow: 9 of 11 periods available· newest 2024-12-31
Capital expenditure: 6 of 11 periods available· newest 2024-12-31
Total assets: 8 of 11 periods available· newest 2024-12-31
Total liabilities: 8 of 11 periods available· newest 2024-12-31
Current assets: 8 of 11 periods available· newest 2024-12-31
Current liabilities: 8 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2024-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2023-12-31
Shares outstanding: 8 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 30.34 million

Prior period

−USD 54.81 million

2023-01-01 – 2023-12-31
Current period

−USD 85.15 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-85148000 − -54810000 = -30338000 USD

-54810000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-85148000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SCPHARMACEUTICALS INC. · 2024-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Year-over-year change in Net income: -30338000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -85148000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#2055800 Filing: 000095017025042159 Input fundies:NetIncome: -54810000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#2054034 Filing: 000095017025042159
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 11.26 million

Prior period

−USD 59.24 million

2023-01-01 – 2023-12-31
Current period

−USD 70.5 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-70500000 − -59244000 = -11256000 USD

-59244000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-70500000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SCPHARMACEUTICALS INC. · 2024-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Year-over-year change in Operating cash flow: -11256000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -70500000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1975181 Filing: 000095017025042159 Input fundies:OperatingCashFlow: -59244000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1864871 Filing: 000095017025042159
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-47.5%

Prior period

USD 40,000

2023-01-01 – 2023-12-31
Current period

USD 21,000

2024-01-01 – 2024-12-31

Exact inputs and evidence

21000 − 40000 = -19000 USD

40000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
21000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SCPHARMACEUTICALS INC. · 2024-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Year-over-year change in Capital expenditure: -19000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 21000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1873240 Filing: 000095017025042159 Input fundies:CapitalExpenditure: 40000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1871497 Filing: 000095017025042159
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 24.38 million Exact value Exact value: -24377000 USD 2016-01-01 – 2016-12-31: -24377000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCPHARMACEUTICALS INC. · 2016-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Net Income: -24377000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24377000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/scph-20181231.xml#102624 Filing: 000156459019008726 The citation records this snapshot. The page link may show a newer release later.	−USD 15.46 million Exact value Exact value: -15455000 USD 2016-01-01 – 2016-12-31: -15455000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCPHARMACEUTICALS INC. · 2016-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Operating Cash Flow: -15455000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15455000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/scph-20181231.xml#127966 Filing: 000156459019008726 The citation records this snapshot. The page link may show a newer release later.	USD 9,000 Exact value Exact value: 9000 USD 2016-01-01 – 2016-12-31: 9000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCPHARMACEUTICALS INC. · 2016-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Capital Expenditure: 9000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/scph-20181231.xml#128602 Filing: 000156459019008726 The citation records this snapshot. The page link may show a newer release later.	−USD 15.46 million Calculation and evidence -15455000 − 9000 USD Exact free cash flow: -15464000 USD 2016-01-01 – 2016-12-31: -15455000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 9000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCPHARMACEUTICALS INC. · 2016-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Free cash flow: -15464000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15455000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/scph-20181231.xml#127966 Filing: 000156459019008726 Input fundies:CapitalExpenditure: 9000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/scph-20181231.xml#128602 Filing: 000156459019008726 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 23.82 million Exact value Exact value: -23817000 USD 2017-01-01 – 2017-12-31: -23817000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCPHARMACEUTICALS INC. · 2017-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Net Income: -23817000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23817000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/scph-20181231.xml#102778 Filing: 000156459019008726 The citation records this snapshot. The page link may show a newer release later.	−USD 22.68 million Exact value Exact value: -22682000 USD 2017-01-01 – 2017-12-31: -22682000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCPHARMACEUTICALS INC. · 2017-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Operating Cash Flow: -22682000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22682000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/scph-20181231.xml#128178 Filing: 000156459019008726 The citation records this snapshot. The page link may show a newer release later.	USD 194,000 Exact value Exact value: 194000 USD 2017-01-01 – 2017-12-31: 194000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCPHARMACEUTICALS INC. · 2017-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Capital Expenditure: 194000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 194000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/scph-20181231.xml#128809 Filing: 000156459019008726 The citation records this snapshot. The page link may show a newer release later.	−USD 22.88 million Calculation and evidence -22682000 − 194000 USD Exact free cash flow: -22876000 USD 2017-01-01 – 2017-12-31: -22682000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 194000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCPHARMACEUTICALS INC. · 2017-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Free cash flow: -22876000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22682000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/scph-20181231.xml#128178 Filing: 000156459019008726 Input fundies:CapitalExpenditure: 194000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459019008726/scph-20181231.xml#128809 Filing: 000156459019008726 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 29.44 million Exact value Exact value: -29443000 USD 2018-01-01 – 2018-12-31: -29443000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCPHARMACEUTICALS INC. · 2018-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Net Income: -29443000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29443000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459020012500/scph-20191231.xml#86498 Filing: 000156459020012500 The citation records this snapshot. The page link may show a newer release later.	−USD 28.81 million Exact value Exact value: -28812000 USD 2018-01-01 – 2018-12-31: -28812000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCPHARMACEUTICALS INC. · 2018-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Operating Cash Flow: -28812000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -28812000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459020012500/scph-20191231.xml#99038 Filing: 000156459020012500 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	−USD 33 million Exact value Exact value: -32996000 USD 2019-01-01 – 2019-12-31: -32996000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCPHARMACEUTICALS INC. · 2019-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Net Income: -32996000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32996000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459021014898/scph-20201231.xml#108101 Filing: 000156459021014898 The citation records this snapshot. The page link may show a newer release later.	−USD 30.44 million Exact value Exact value: -30442000 USD 2019-01-01 – 2019-12-31: -30442000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCPHARMACEUTICALS INC. · 2019-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Operating Cash Flow: -30442000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30442000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000156459021014898/scph-20201231.xml#123889 Filing: 000156459021014898 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 32.21 million Exact value Exact value: -32209000 USD 2020-01-01 – 2020-12-31: -32209000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCPHARMACEUTICALS INC. · 2020-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Net Income: -32209000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32209000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017022004297/scph-20211231.htm#1935842 Filing: 000095017022004297 The citation records this snapshot. The page link may show a newer release later.	−USD 27.69 million Exact value Exact value: -27693000 USD 2020-01-01 – 2020-12-31: -27693000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCPHARMACEUTICALS INC. · 2020-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Operating Cash Flow: -27693000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27693000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017022004297/scph-20211231.htm#1782218 Filing: 000095017022004297 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 28.03 million Exact value Exact value: -28034000 USD 2021-01-01 – 2021-12-31: -28034000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCPHARMACEUTICALS INC. · 2021-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Net Income: -28034000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28034000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017023009201/scph-20221231.htm#2228490 Filing: 000095017023009201 The citation records this snapshot. The page link may show a newer release later.	−USD 27.15 million Exact value Exact value: -27151000 USD 2021-01-01 – 2021-12-31: -27151000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCPHARMACEUTICALS INC. · 2021-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Operating Cash Flow: -27151000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27151000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017023009201/scph-20221231.htm#2048316 Filing: 000095017023009201 The citation records this snapshot. The page link may show a newer release later.	USD 9,000 Exact value Exact value: 9000 USD 2021-01-01 – 2021-12-31: 9000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCPHARMACEUTICALS INC. · 2021-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Capital Expenditure: 9000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017023009201/scph-20221231.htm#2056309 Filing: 000095017023009201 The citation records this snapshot. The page link may show a newer release later.	−USD 27.16 million Calculation and evidence -27151000 − 9000 USD Exact free cash flow: -27160000 USD 2021-01-01 – 2021-12-31: -27151000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 9000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCPHARMACEUTICALS INC. · 2021-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Free cash flow: -27160000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27151000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017023009201/scph-20221231.htm#2048316 Filing: 000095017023009201 Input fundies:CapitalExpenditure: 9000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017023009201/scph-20221231.htm#2056309 Filing: 000095017023009201 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 36.84 million Exact value Exact value: -36838000 USD 2022-01-01 – 2022-12-31: -36838000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCPHARMACEUTICALS INC. · 2022-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Net Income: -36838000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36838000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017024030780/scph-20231231.htm#1757578 Filing: 000095017024030780 The citation records this snapshot. The page link may show a newer release later.	−USD 34.58 million Exact value Exact value: -34577000 USD 2022-01-01 – 2022-12-31: -34577000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCPHARMACEUTICALS INC. · 2022-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Operating Cash Flow: -34577000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34577000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017024030780/scph-20231231.htm#1607521 Filing: 000095017024030780 The citation records this snapshot. The page link may show a newer release later.	USD 21,000 Exact value Exact value: 21000 USD 2022-01-01 – 2022-12-31: 21000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCPHARMACEUTICALS INC. · 2022-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Capital Expenditure: 21000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017024030780/scph-20231231.htm#1612879 Filing: 000095017024030780 The citation records this snapshot. The page link may show a newer release later.	−USD 34.6 million Calculation and evidence -34577000 − 21000 USD Exact free cash flow: -34598000 USD 2022-01-01 – 2022-12-31: -34577000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 21000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCPHARMACEUTICALS INC. · 2022-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Free cash flow: -34598000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -34577000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017024030780/scph-20231231.htm#1607521 Filing: 000095017024030780 Input fundies:CapitalExpenditure: 21000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017024030780/scph-20231231.htm#1612879 Filing: 000095017024030780 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 54.81 million Exact value Exact value: -54810000 USD 2023-01-01 – 2023-12-31: -54810000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCPHARMACEUTICALS INC. · 2023-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Net Income: -54810000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -54810000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#2054034 Filing: 000095017025042159 The citation records this snapshot. The page link may show a newer release later.	−USD 59.24 million Exact value Exact value: -59244000 USD 2023-01-01 – 2023-12-31: -59244000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCPHARMACEUTICALS INC. · 2023-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Operating Cash Flow: -59244000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -59244000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1864871 Filing: 000095017025042159 The citation records this snapshot. The page link may show a newer release later.	USD 40,000 Exact value Exact value: 40000 USD 2023-01-01 – 2023-12-31: 40000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCPHARMACEUTICALS INC. · 2023-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Capital Expenditure: 40000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 40000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1871497 Filing: 000095017025042159 The citation records this snapshot. The page link may show a newer release later.	−USD 59.28 million Calculation and evidence -59244000 − 40000 USD Exact free cash flow: -59284000 USD 2023-01-01 – 2023-12-31: -59244000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 40000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCPHARMACEUTICALS INC. · 2023-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Free cash flow: -59284000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -59244000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1864871 Filing: 000095017025042159 Input fundies:CapitalExpenditure: 40000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1871497 Filing: 000095017025042159 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 85.15 million Exact value Exact value: -85148000 USD 2024-01-01 – 2024-12-31: -85148000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCPHARMACEUTICALS INC. · 2024-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Net Income: -85148000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -85148000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#2055800 Filing: 000095017025042159 The citation records this snapshot. The page link may show a newer release later.	−USD 70.5 million Exact value Exact value: -70500000 USD 2024-01-01 – 2024-12-31: -70500000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCPHARMACEUTICALS INC. · 2024-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Operating Cash Flow: -70500000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -70500000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1975181 Filing: 000095017025042159 The citation records this snapshot. The page link may show a newer release later.	USD 21,000 Exact value Exact value: 21000 USD 2024-01-01 – 2024-12-31: 21000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCPHARMACEUTICALS INC. · 2024-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Capital Expenditure: 21000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1873240 Filing: 000095017025042159 The citation records this snapshot. The page link may show a newer release later.	−USD 70.52 million Calculation and evidence -70500000 − 21000 USD Exact free cash flow: -70521000 USD 2024-01-01 – 2024-12-31: -70500000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 21000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCPHARMACEUTICALS INC. · 2024-12-31 SCPHARMACEUTICALS INC. (edgar:1604950) Free cash flow: -70521000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:43:53Z Snapshot: 842c0a873062b4e0fde43204e07cf6e688c60f8edc74f5e2f78c8d5a2503b595 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1604950?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -70500000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1975181 Filing: 000095017025042159 Input fundies:CapitalExpenditure: 21000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1604950/000095017025042159/scph-20241231.htm#1873240 Filing: 000095017025042159 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

37 filings · 1,833 latest values · 1,833 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001604950, 1604950, SCPH, edgar:1604950

Also known as SCPHARMACEUTICALS INC., SCPHARMACEUTICALS INC., scPharmaceuticals Inc.

SCPHARMACEUTICALS INC.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation